Targeting tumor associated macrophages (TAMs) reprograms tumor immune microenvironment to promote solid tumor immunotherapy

Chunliu Huang(Fujian Medical University), Jun Chen(The University of Texas MD Anderson Cancer Center), Zijin Xia(Sun Yat-sen University), Lixiang Wang(Sun Yat-sen University), Xinyu Wang(Sun Yat-sen University), Xiumei Wang(State Key Laboratory of New Ceramics and Fine Processing), Yujia Liu(Sun Yat-sen University)
Cellular Oncology
September 5, 2024
10.1007/s13402-024-00987-x
Cited by 6

Related Papers

Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response
|Nature Cancer|2023|219
Aligned chitosan nanofiber hydrogel grafted with peptides mimicking bioactive brain-derived neurotrophic factor and vascular endothelial growth factor repair long-distance sciatic nerve defects in rats
|Theranostics|2020|201
A fully biodegradable and self-electrified device for neuroregenerative medicine
|Science Advances|2020|188
Structural insight reveals SARS-CoV-2 ORF7a as an immunomodulating factor for human CD14+ monocytes
|iScience|2021|134
A snoRNA modulates mRNA 3′ end processing and regulates the expression of a subset of mRNAs
|Nucleic Acids Research|2017|113